N-Ethylmaleimide (NEM) inhibits protein transport between successive compartments of the Golgi stack in a cell-free system. After inactivation of the Golgi membranes by NEM, transport can be rescued by adding back an appropriately prepared cytosol fraction. This complementation assay has allowed us to purify the NEM-sensitive factor, which we term NSF. The NEM-sensitive factor is a tetramer of 76-kDa subunits, and appears to act catalytically, one tetramer leading to the metabolism of numerous transport vesicles.
transport assay. Transport could be restored to NEM-treated Golgi membranes by adding back the ATP extract of untreated Golgi membranes. This restorative factor was itself sensitive to NEM. The activity of NSF is stimulated by long chain fatty acyl-CoA (2, 3) . NSF is required for transport at multiple levels of the Golgi stack (3). Here we report the purification of NSF from CHO cytosol prepared in the presence of ATP.
MATERIALS AND METHODS
Preparation of Golgi Membranes and NSF-Free Cytosol. Donor and acceptor membranes were prepared as described (8, 15) from VSV-infected 15B CHO and wild-type uninfected CHO cells, respectively. A mixture of equal volumes of acceptor and donor Golgi membranes (in 1 M sucrose/10 mM Tris HCI, pH 7.4) was incubated at 00C for 15 min with 1 mM NEM (final concentration) added from a fresh stock solution (50 mM). Then dithiothreitol was added to 2 mM from a 0.1 M stock. This mixture of NEM-treated donor and acceptor membranes was refrozen in liquid N2 and stored in aliquots at -80'C for use in NSF assays.
15B CHO cells were grown and homogenized (15) . Cytosol (8 mg/ml of protein) was prepared and desalted on a Bio-Gel P6-DG column essentially as described (8, 15) , incubated for 20 min at 370C in the absence of ATP to inactivate any NSF, frozen in liquid nitrogen, and stored at -80'C.
Assay of NSF Activity. The assay used is a variation on the standard transport assay (8 The NSF fraction to be tested (up to 20 pl) was added last. After incubation at 370C for 1 hr, the VSV-G protein was immunoprecipitated at 40C for at least 6 hr as described (8) . Assays of all fractions were performed in a predetermined linear range (0-0.2 mg/ml for crude ATPstabilized cytosol). Large-Scale Preparation of ATP-Containing Cytosol for NSF Purifications. A washed pellet of CHO cells (1 vol) was resuspended with 4 vol of swelling buffer containing 20 mM Pipes-KOH (pH 7.2), 10 mM MgCl2, 5 mM ATP, 5 mM dithiothreitol, 1 mM phenylmethylsulfonyl fluoride, 0.5 mM o-phenanthroline, leupeptin (10 ,ug/ml), and 1 ,M pepstatin. The cells were allowed to swell 20 min on ice and then were disrupted in a Waring Blendor at high speed for 30 sec. Then, KCI was added slowly to the homogenate while stirring to achieve a final concentration of 0.1 M from a 2.5 M stock solution. After low-speed centrifugation at 800 x g for 15 min, the postnuclear supernatant was frozen in 45-ml aliquots in liquid nitrogen and stored at -80'C. When cytosol was required, postnuclear supernatant (rapidly thawed at 37°C) was spun at 45,000 rpm in a 45 Ti rotor for 90 min. This supernatant was the cytosol used for purification.
Purification of NSF. Fresh dithiothreitol was added to all buffers immediately before use. The purification described here is a standard one designed for 450 ml of cytosol and employs tandem DE-52 (Whatman) and S Sepharose Fast Flow (Pharmacia) columns. The purification described in the text and Table 1 and Figs. 2 and 3 employed 120 ml of cytosol (600 mg of protein) and is meant to illustrate each step Abbreviations: NEM, N-ethylmaleimide; NSF, NEM-sensitive factor; VSV-G protein, vesicular stomatitis virus-encoded glycoprotein. *Present address: Department of Molecular Biology, Lewis Thomas Laboratory, Princeton University, Princeton, NJ 08544.
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The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact. 10 ,000 rpm in a JA-20 rotor (Beckman). The pellet was suspended in one-third ofthe initial volume in a solution of 100 mM KCI, 20 mM Pipes-KOH (pH 7), 2 mM MgCl2, 2 mM dithiothreitol, and 0.5 mM ATP. The suspension was homogenized with a Dounce homogenizer and then sonicated with three 10-sec bursts in a waterbath sonicator at 00C. Undissolved protein was then removed by a second centrifugation at 10,000 rpm in the JA-20 rotor for 15 min. These conditions must be carefully followed for reproducible results.
Ion-Exchange Chromatography (Tandem DE-52 and S Sepharose Fast Flow Columns). DEAE-cellulose resin (DE-52) was swollen in a solution of 1 M Pipes-KOH (pH 7) and 0.5 M KCl and then poured into a 120-ml column (2.5 cm x 24 cm). S Sepharose Fast Flow was equilibrated with a 2 M KCl solution and then poured into a 50-ml glass column (2.5 cm x 10 cm). The columns were connected in series, equilibrated with a solution of 20 mM Pipes (pH 7), 100 mM KCI, 2 mM MgCi2, 2 mM dithiothreitol, and 0.5 mM ATP, and run at 2.5 ml/min. Fractions (8 ml) were collected. The protein concentration of fractions was measured by the Bradford method (5). The flow through protein peak (typically fractions 12-28) was concentrated 20-fold by ultrafiltration on an Amicon XM300 membrane at 0°C. The concentrate was centrifuged 15 min at 25,000 x g to remove precipitated material. ATP will flow through the DE-52 column at the concentration of KCI (0.1 M) used.
Sedimentation on Glycerol Gradients. Linear 10-35% (wt/vol) glycerol gradients (38 ml) were formed from the bottom of 40-ml Beckman quick-seal tubes. The buffer throughout the gradient was 20 mM Hepes-KOH (pH 7), 100 mM KCl, 2 mM MgCl2, 2 mM dithiothreitol, and 0.5 mM ATP. The concentrated DE-52/S Sepharose Fast Flow flowthrough peak was layered on the top of each gradient in 2-ml portions by using a peristaltic pump. The gradients were centrifuged in a Beckman VTi 50 rotor at 50,000 rpm for 2.5 hr by using a slow acceleration and deceleration program. Typically, three gradients were required to process NSF derived from 450 ml ofcytosol. Fractions (2 ml) were collected from the bottom of the tube. The protein concentration and NSF activity (in 0.1 ,ul samples) of each fraction were measured. The most active fractions (typically fractions 9-13, see Fig. 2 ) were pooled, yielding -1.5 mg of protein per ml.
Mono S FPLC Chromatography. The pooled glycerol gradient fraction was concentrated 2-fold by ultrafiltration (XM300 membrane) and dialyzed in Spectrapor 2 tubing (Spectrum Medical Industries, Los Angeles) against 100 vol of a solution of 20 mM Hepes-KOH (pH 7), 10% (wt/vol) glycerol, 2 mM MgCl2, 2 mM dithiothreitol, and 0.5 mM ATP for a total of 2 hr at 40C (with one buffer change). The dialysate was centrifuged for 10 min at 10,000 rpm in the JA-20 rotor, and 8-ml portions of the clear supernatant were loaded onto a 1-ml Mono S column (preequilibrated with the dialysis buffer) at a flow rate of 0.5 ml/min. After a 15-ml wash, NSF activity was eluted with a 10-ml linear gradient of 0-100 mM KCl. Activity was mainly found in two 0.5-ml fractions at =60 mM KCl. Then the column was "stripped" with 2 M KCI before reuse. Two runs were necessary to process the entire preparation. NSF (-0.15 mg/ml) was frozen in aliquots in liquid N2 and stored at -80'C. NSF could be repeatedly frozen in liquid N2 with little loss of activity.
Monoclonal [15] ), some NSF activity was usually found in the cytosol fraction but was lost within an hour on ice. This cytosolic NSF activity was inactivated during the time required for gel-filtration, explaining our inability to detect it previously (2). ATP) was diluted 1:10 with a buffer containing 100 mM KCI, 20 mM Pipes-KOH (pH 7), 2 mM MgCl2, and 2 mM dithiothreitol, and ATP was added as needed to achieve the indicated final concentration.
These mixtures were then preincubated at 370C and samples were removed (and chilled on ice) for assaying the amount of NSF activity remaining as a function of time at 370C.
Crucial to the success of the purification was the finding that ATP stabilizes extracted NSF activity, in addition to its role in extraction. Fig. 1 shows that ATP markedly protects NSF against thermal denaturation at 370C. Activity is lost and to a lesser extent in buffer containing sulfate ion, but in the absence of these ions NSF is stable over a broad pH range (pH 6.5-8).
Purification of NSF. Cytosol prepared from a 120-liter culture of CHO cells was precipitated with PEG, and then passed through successive DE-52 and S Sepharose-Fast Flow columns, to which NSF does not bind. Then, NSF (sedimenting at 12 S) was effectively separated from bulk protein by velocity sedimentation through a glycerol gradient (Fig.  2) . Mono S FPLC (Pharmacia) (Fig. 3) was used as the final step. NSF was retained on the Mono S column at the low-salt concentration employed. NSF activity eluted in a sharp peak in a KCl gradient at -60 mM KCI (Fig. 3A) . The peak of activity coincided with a peak of absorbance at 280 nm. The peak fractions (fractions 43 and 44 in Fig. 3A) were pooled and contained NSF purified 1000-fold relative to cytosol, with an overall yield of 12% in activity. It is very likely that this degree of purification is an underestimate due to inactivation of NSF during cation-exchange steps (steps 4 and 6). About 140 utg of NSF were obtained from 120 ml of CHO cytosol (600 mg of protein). Based on the yields in the purification, we estimate that NSF accounts for between 0.02% and 0.2% of the cytosolic protein (the exact number depending on the extent of inactivation during purification).
NSF Is Most Likely a Tetramer of 76-kDa Polypeptide Chains. A single polypeptide of =76 kDa coelutes with NSF activity from the FPLC Mono S column (Fig. 3B) . The 76-kDa polypeptide precisely cosedimented with NSF activity at 12 S in analytical glycerol velocity gradients (data not shown). Based on the elution volume of NSF activity relative to a standard series of markers during FPLC gel filtration with Superose 12, we calculated the Stoke's radius of NSF to be 63 A (data not shown). Combining the Stoke's radius with the sedimentation constant, we estimate that the native molecular mass of NSF is 307 kDa. Thus, it would appear that NSF is a tetramer of 76-kDa polypeptide chains.
The excellent correlation ofNSF activity with the presence of the 76-kDa subunit provides strong evidence that this polypeptide chain is indeed NSF. The activity of the purified NSF fraction is completely eliminated by treatment with 1 mM NEM at 0C, and under these same conditions the 76-kDa polypeptide is labeled with [14C]NEM (data not shown). The activity of purified NSF (data not shown) is stimulated by long-chain acyl-CoA in a fashion similar to that of crude NSF (2) .
Monoclonal Antibodies to NSF. To establish definitively that the 76-kDa polypeptide chain is the active subunit of NSF, we prepared murine monoclonal antibodies against purified NSF. An IgM (from hybridoma clone 4A6) was obtained that reacted with purified NSF in an RIA but not in immunoblots. We could confirm that the IgM antibody was directed at the 76-kDa polypeptide (putatively NSF) by immunopurification of this band from cytosol under native conditions (Fig. 4) . The 76-kDa chain was bound by the IgM 4A6 (lane 4) but not the control IgM (lane 3). This 76-kDa antigen and purified NSF had identical partial proteolysis (17) maps (data not shown). We conclude that the IgM 4A6 is directed against the major 76-kDa chain in the NSF preparation.
The anti-76-kDa chain IgM strongly inhibited the transport reaction, whereas the control IgM did not (Fig. 5) . This inhibition could be overcome by purified NSF. Adding 0.25 ,ug of purified NSF led to a requirement for an additional 0.8 ,ug of IgM 4A6 for 50% inhibition (Fig. 5) , corresponding to -0.96 mol of IgM pentamer per mol of NSF tetramer.
We conclude that the 76-kDa chain contains NSF activity and that an IgM directed against this polypeptide inhibits the ability of NSF to promote transport. and then re-equilibrated in the column buffer at pH 7. Two IgM antibodies were employed, 4A6 that is directed against NSF and 1C2 that is a control IgM purified from ascites fluid and directed against an unrelated cytosolic antigen (provided by V. Malhotra and M.
Paquet of this laboratory). Each resin (250'AL) was incubated with 2 ml of CHO cytosol (5 mg/ml, prepared with ATP and KCI) for 2 hr at 4°C with gentle stirring. Then, the suspension was poured into a small column and washed with 8 ml of column buffer. Specifically bound proteins were then eluted with 2 ml of 0.2 M glycine hydrochloride plus 10%o (vol/vol) glycerol (pH 2). Samples of the unbound proteins (flow-through of the column) and specifically bound proteins (the pH 2 eluate) were then analyzed by SDS/gel electrophoresis (10%6 gel, stained with Coomassie blue). Samples of equivalent volume were electrophoresed for the control and anti-NSF columns. Samples were precipitated with 10% (wt/vol) trichloroacetic acid before electrophoresis. Lanes: 1 and 2, flowthrough fractions of control (1C2) and anti-NSF (4A6) antibody columns, respectively; 3 and 4, proteins eluted at pH 2 from control and anti-NSF columns, respectively; 5, purified NSF (1.5 ,ug (Fig. 4) . However, a very small polypeptide chain might have escaped notice. It remains a formal possibility that there is heterogeneity among the 76-kDa subunits. However, partial Nterminal amino acid sequence analysis of cyanogen bromide peptides (accounting for a total of 171 residues-20-25% of the polypeptide chain' data not shown) offers no evidence of heterogeneity. Also, none of these fragments have significant homology with any known protein sequences in the National Biomedical Research Foundation Databank (April 1988) including the hsp7O gene family. Thus, it appears that the NSF polypeptide is a functional unit that has not been described to our knowledge.
NSF was purified on the basis of its ability to restore transport between the cis and medial (16) Golgi compartments in which the transport-coupled incorporation of [3H]GlcNAc is measured (8) and partially purified NSF restores transport in a transport-coupled sialylation assay (3) that measures movement of the VSV-G protein into the trans-Golgi compartment. The 4A6 anti-NSF antibody also inhibits this latter movement (data not shown), which would suggest that NSF acts at multiple levels within the Golgi stack.
A simple calculation suggests that NSF acts catalytically rather than stoichiometrically in promoting transport and is thus recycled. About 0.2 pmol of VSV-G protein is transported into the medial Golgi compartment (15) . A typical vesicle (70 nm in diameter) will contain an average of about 10 VSV-G protein molecules, based on available data (12, 18) . Therefore, the transport of 0.2 pmol of VSV-G protein from cis to medial Golgi compartments will require 1.5 x 1010 vesicles. The total number of vesicles formed (at-all levels of the stack) will clearly be several times greater. Saturating levels of transport are observed when 2.6 ng of pure NSF is added to standard (50 ILI) transport assay mixtures (data not shown); this corresponds to 5 x 109 NSF tetramers, assuming all tetramers are active. In summary, one tetramer added to the assay mixture is sufficient to metabolize at least three transport vesicles en route from cis to medial Golgi compartments. This is undoubtedly a gross underestimate, because the extensive loss of activity during the purification implies that only a small fraction of the purified NSF is actually functional and because only a fraction of the NSF added is likely to serve in the cis medial step being considered.
We have described (19) a series of biochemical and morphological studies that reveal a role for NSF in catalyzing the fusion of transport vesicles with Golgi cisternae.
